Paraneoplastic neuromyelitis optica spectrum disorders: three new cases and a review of the literature

References

• Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol 2007;6:805–15.
   PubMed Web of Science ®Google Scholar
• Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364:2106–12.
   PubMed Web of Science ®Google Scholar
• Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66:1485–9.
   PubMed Web of Science ®Google Scholar
• Pittock SJ, Lennon VA. Aquaporin-4 autoantibodies in a paraneoplastic context. Arch Neurol 2008;65:629–32.
   PubMed Web of Science ®Google Scholar
• Mueller S, Dubal DB, Josephson SA. A case of paraneoplastic myelopathy associated with the neuromyelitis optica antibody. Nat Clin Pract Neurol 2008;4:284–8.
   PubMedGoogle Scholar
• Armağan H, Tüzün E, Içöz S, et al. Long extensive transverse myelitis associated with aquaporin-4 antibody and breast cancer: favorable response to cancer treatment. J Spinal Cord Med 2012;35:267–9.
   PubMed Web of Science ®Google Scholar
• Ontaneda D, Fox RJ. Is neuromyelitis optica with advanced age of onset a paraneoplastic disorder? Int J Neurosci 2014;124:509–11.
   PubMed Web of Science ®Google Scholar
• De Santis G, Caniatti L, De Vito A, et al. A possible paraneoplastic neuromyelitis optica associated with lung cancer. Neurol Sci 2009;30:397–400.
   PubMed Web of Science ®Google Scholar
• Iorio R, Rindi G, Erra C, et al. Neuromyelitis optica spectrum disorder as a paraneoplastic manifestation of lung adenocarcinoma expressing aquaporin-4. Mult Scler 2015;21(6):791–4.
   PubMed Web of Science ®Google Scholar
• Yang HK, Woo SJ, Park WY, Hwang JM. Paraneoplastic neuromyelitis optica associated with ANNA-1 antibodies in invasive thymoma. BMC Ophthalmol 2014;14:106.
   PubMed Web of Science ®Google Scholar
• Kitazawa Y, Warabi Y, Bandoh M, et al. Elderly-onset neuromyelitis optica which developed after the diagnosis of prostate adenocarcinoma and relapsed after a 23-valent pneumococcal polysaccharide vaccination. Intern Med 2012;51:103–7.
   PubMed Web of Science ®Google Scholar
• Nakayama-Ichiyama S, Yokote T, Hiraoka N, et al. A paraneoplastic neuromyelitis optica spectrum disorder associated with a mature B-cell neoplasm. Leuk Res 2011;35:e111–3.
   PubMed Web of Science ®Google Scholar
• Figueroa M, Guo Y, Tselis A, et al. Paraneoplastic neuromyelitis optica spectrum disorder associated with metastatic carcinoid expressing aquaporin-4. JAMA Neurol 2014;71:495–8.
   PubMed Web of Science ®Google Scholar
• Al-Harbi T, Al-Sarawi A, Binfalah M, Dermime S. Paraneoplastic neuromyelitis optica spectrum disorder associated with stomach carcinoid tumor. Hematol Oncol Stem Cell Ther 2014;7:116–9.
   PubMedGoogle Scholar
• Frasquet M, Bataller L, Torres-Vega E, et al. Longitudinally extensive transverse myelitis with AQP4 antibodies revealing ovarian teratoma. J Neuroimmunol 2013;263:145–7.
   PubMed Web of Science ®Google Scholar
• Zoccarato M, Saddi MV, Serra G, et al. Aquaporin-4 antibody neuromyelitis optica following anti-NMDA receptor encephalitis. J Neurol 2013;260:3185–7.
   PubMed Web of Science ®Google Scholar
• Collongues N, Marignier R, Zéphir H, et al. Neuromyelitis optica in France: a multicenter study of 125 patients. Neurology 2010;74:736–42.
   PubMed Web of Science ®Google Scholar
• Stich O, Murek C, Rasiah C, Rauer S. Screening for well-characterized paraneoplastic antineuronal antibodies in multiple sclerosis. Int J Neurosci 2011;121:477–9.
   PubMed Web of Science ®Google Scholar
• Marrie R, Horwitz R, Cutter G, et al. Comorbidity, socioeconomic status and multiple sclerosis. Mult Scler 2008; 14:1091–8.
   PubMed Web of Science ®Google Scholar
• Apiwattanakul M, Popescu BF, Matiello M, et al. Intractable vomiting as the initial presentation of neuromyelitis optica. Ann Neurol 2010;68:757–61.
   PubMed Web of Science ®Google Scholar
• Verkman AS. Aquaporins in clinical medicine. Annu Rev Med 2012;63:303–16.
   PubMed Web of Science ®Google Scholar
• The Human Protein Atlas. Cancer Atlas. Available from: http://www.proteinatlas.org/ [ accessed 20 December 2014].
   Google Scholar
• Chan KH, Kwan JS, Ho PW, et al. Aquaporin-4 water channel expression by thymoma of patients with and without myasthenia gravis. J Neuroimmunol 2010;227:178–84.
   PubMed Web of Science ®Google Scholar
• Iorio R, Lucchinetti CF, Lennon VA, et al. Syndrome of inappropriate antidiuresis may herald or accompany neuromyelitis optica. Neurology 2011;77:1644–46.
   PubMed Web of Science ®Google Scholar
• Hofman P, Hoyng P, vanderWerf F, et al. Lack of blood-brain barrier properties in microvessels of the prelaminar optic nerve head. Invest Ophthalmol Vis Sci 2001;42:895–901.
   PubMed Web of Science ®Google Scholar
• Bartanusz V, Jezova D, Alajajian B, Digicaylioglu M. The blood-spinal cord barrier: morphology and clinical implications. Ann Neurol 2011;70:194–206.
   PubMed Web of Science ®Google Scholar
• Papadopoulos MC, Verkman AS. Aquaporin 4 and neuromyelitis optica. Lancet Neurol 2012;11:535–44.
   PubMed Web of Science ®Google Scholar
• Itou J, Tanaka S, Sato F, et al. An optical labeling-based proliferation assay system reveals the paracrine effect of interleukin-6 in breast cancer. Biochim Biophys Acta 2015;1853:27–40.
   PubMed Web of Science ®Google Scholar
• Jarius S, Wandinger KP, Borowski K, et al. Antibodies to CV2/CRMP5 in neuromyelitis optica-like disease: case report and review of the literature. Clin Neurol Neurosurg. 2012;114:331–5.
   PubMed Web of Science ®Google Scholar
• Ducray F, Roos-Weil R, Garcia PY, et al. Devic's syndrome-like phenotype associated with thymoma and anti-CV2/CRMP5 antibodies. J Neurol Neurosurg Psychiatry 2007;78:325–7.
   PubMed Web of Science ®Google Scholar
• Pittock SJ, Lucchinetti CF, Parisi JE, et al. Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol 2005;58:96–107.
   PubMed Web of Science ®Google Scholar
• Vernino S, Eggenberger ER, Rogers LR, Lennon VA. Paraneoplastic neurological autoimmunity associated with ANNA-1 autoantibody and thymoma. Neurology 2002;59:929–32.
   PubMed Web of Science ®Google Scholar